会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明授权
    • 1-heteruarylazetidines and -pyrrolidines, process for their preparation
and pharmaceutical compositions containing them
    • 1-杂芳基氮杂环丁烷和吡咯烷,其制备方法和含有它们的药物组合物
    • US5576320A
    • 1996-11-19
    • US466912
    • 1995-06-06
    • Marco BaroniUmberto GuzziAntonina GiudiceMarco LandiVivian Mazza
    • Marco BaroniUmberto GuzziAntonina GiudiceMarco LandiVivian Mazza
    • A61K31/44A61K31/4427A61K31/495A61K31/505A61P1/00A61P25/00A61P43/00C07D401/04C07D403/04A61K31/50
    • C07D401/04C07D403/04
    • The present invention relates to new 1-heteroarylazetidines and new 1-heteroarylpyrrolidines endowed with 5-HT.sub.3 agonist activity of formula (I): ##STR1## in which A is --CH.dbd.N-- or --N.dbd.CH--; R is hydrogen, halogen, C.sub.1-4 alkyl, C.sub.1-4 alkoxy, C.sub.1-4 alkylthio, cyano, carboxamido, trifluoromethyl, a vinyl group, a formyl group, a carboxyl group in free, salt or esterified form, hydroxyl, hydroxymethyl, mercapto, amine, mono- or di-(C.sub.1-4 alkyl)amino, aminomethyl, mono- or di(C.sub.1-4 alkyl)aminomethyl, 1-piperido, 1-pyrrolidino, 1-piperazino or 4-(C.sub.1-4 alkyl)-1-piperazino, where R may replace any one of the hydrogen atoms of the heteroaryl nucleus;R.sub.1 is hydrogen or a methyl group;R.sub.2 and R.sub.3, which are identical or different, are hydrogen or C.sub.1-4 alkyl;n is 1 or 2; m is 0 or 1; and m+n.gtoreq.2;and addition salts with inorganic or organic acids of the compounds of formula (I). The invention also relates to pharmaceutical compositions containing these compounds, as well as to methods of treatment or prophylaxis of disorders which involve the peripheral or central serotoninergic systems.
    • 本发明涉及新的1-杂芳基氮杂环丁烷和赋予式(I)的5-HT 3激动剂活性的新的1-杂芳基吡咯烷酮:其中A是-CH = N-或-N = CH-; R是氢,卤素,C 1-4烷基,C 1-4烷氧基,C 1-4烷硫基,氰基,甲酰氨基,三氟甲基,乙烯基,甲酰基,游离的羧基,盐或酯化形式,羟基,羟甲基,巯基,胺 ,单 - 或二 - (C 1-4烷基)氨基,氨基甲基,一或二(C 1-4烷基)氨基甲基,1-哌啶基,1-吡咯烷子基,1-哌嗪基或4-(C 1-4烷基)-1-哌嗪基, 其中R可以代替杂芳基核的任何一个氢原子; R1是氢或甲基; R2和R3相同或不同,为氢或C1-4烷基; n为1或2; m为0或1; 和m + n> / = 2; 和与式(I)化合物的无机酸或有机酸的加成盐。 本发明还涉及含有这些化合物的药物组合物,以及治疗或预防涉及周围或中枢血清素能系统的病症的方法。
    • 6. 发明授权
    • 1-heteroarylazetidines and -pyrrolidines process for their preparation
and pharmaceutical compositions containing them
    • 1-杂芳基氮杂环丁烷和吡咯烷的制备方法和含有它们的药物组合物
    • US5565474A
    • 1996-10-15
    • US368915
    • 1995-01-05
    • Marco BaroniUmberto GuzziAntonina GiudiceMarco LandiVivian Mazza
    • Marco BaroniUmberto GuzziAntonina GiudiceMarco LandiVivian Mazza
    • A61K31/44A61K31/4427A61K31/495A61K31/505A61P1/00A61P25/00A61P43/00C07D401/04C07D403/04
    • C07D401/04C07D403/04
    • The present invention relates to new 1-heteroarylazetidines and new 1-heteroarylpyrrolidines endowed with 5-HT.sub.3 agonist activity of formula (I): ##STR1## in which A is --CH=CH--; R is hydrogen, halogen, C.sub.1-4 alkyl, C.sub.1-4 alkoxy, C.sub.1-4 alkylthio, cyano, carboxamido, trifluoromethyl, a vinyl group, a formyl group, a carboxyl group in free, salt or esterified form, hydroxyl, hydroxymethyl, mercapto, amino, mono- or di-(C.sub.1-4 alkyl)amino, aminomethyl, mono- or di(C.sub.1-4 alkyl)aminomethyl, 1-piperido, 1-pyrrolidino, 1-piperazino or 4-(C.sub.1-4 alkyl)-1-piperazino, where R may replace any one of the hydrogen atoms of the heteroaryl nucleus;R.sub.1 is hydrogen or a methyl group;R.sub.2 and R.sub.3, which are identical or different, are hydrogen or C.sub.1-4 alkyl;n is 1 or 2; m is 0 or 1; and m+n.gtoreq.2;and addition salts with inorganic or organic acids of the compounds of formula (I). The invention also relates to pharmaceutical compositions containing these compounds, as well as to methods of treatment or prophylaxis of disorders which involve the peripheral or central serotoninergic systems.
    • 本发明涉及新的1-杂芳基氮杂环丁烷和赋予式(I)的5-HT 3激动剂活性的新的1-杂芳基吡咯烷酮:其中A是-CH = CH-; R是氢,卤素,C 1-4烷基,C 1-4烷氧基,C 1-4烷硫基,氰基,甲酰氨基,三氟甲基,乙烯基,甲酰基,游离的羧基,盐或酯化形式,羟基,羟甲基,巯基,氨基 ,单 - 或二 - (C 1-4烷基)氨基,氨基甲基,一或二(C 1-4烷基)氨基甲基,1-哌啶基,1-吡咯烷子基,1-哌嗪基或4-(C 1-4烷基)-1-哌嗪基, 其中R可以代替杂芳基核的任何一个氢原子; R1是氢或甲基; R2和R3相同或不同,为氢或C1-4烷基; n为1或2; m为0或1; 和m + n> / = 2; 和与式(I)化合物的无机酸或有机酸的加成盐。 本发明还涉及含有这些化合物的药物组合物,以及治疗或预防涉及周围或中枢血清素能系统的病症的方法。